Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2014 April;80(4) > Minerva Anestesiologica 2014 April;80(4):495-503

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

EXPERT OPINION  FREEfree


Minerva Anestesiologica 2014 April;80(4):495-503

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Pneumonia in immunocompetent patients: combination antibiotic therapy

Salva S. 1, Borgatta B. 2, Rello J. 2, 3, 4

1 Department of Anesthesia, Vall d’Hebron University Hospital, Barcelona, Spain; 2 Department of Intensive Care, Vall d’Hebron University Hospital, Barcelona, Spain; 3 CIBERES, Barcelona, Spain; 4 Universitat Autonoma de Barcelona, Barcelona, Spain


FULL TEXT  


Pneumonia’s burden is still important worldwide not only because of its high incidence and mortality, but also for the elevated costs related to it. Despite the concerted efforts to reduce the incidence of sepsis-related complications, they continue to represent a major human and economic burden. The cornerstone of sepsis management is early appropriate empiric broad spectrum antibiotics, resuscitation, and source control. The association between inappropriate use of antibiotics and increased mortality is the rationale for the use of empiric antibiotic combination therapy in critically ill patients. The aim of this manuscript was to discuss recent literature regarding the management of severe pneumonia, both community-acquired and hospital-acquired/ventilator-associated, in critically ill patients. Use of combination therapy is warranted in severe infections with shock; considerations should be made on the importance of optimal antibiotic administration and adverse reactions, thus providing guidance for a rational use of antibiotics.

top of page

Publication History

Cite this article as

Corresponding author e-mail

jrello@crips.es